135 related articles for article (PubMed ID: 31668465)
1. Modification on the 1,2-dihydro-2-oxo-pyridine-3-carboxamide core to obtain multi-target modulators of endocannabinoid system.
Gado F; Arena C; Fauci C; Reynoso-Moreno I; Bertini S; Digiacomo M; Meini S; Poli G; Macchia M; Tuccinardi T; Gertsch J; Chicca A; Manera C
Bioorg Chem; 2020 Jan; 94():103353. PubMed ID: 31668465
[TBL] [Abstract][Full Text] [Related]
2. Polypharmacological profile of 1,2-dihydro-2-oxo-pyridine-3-carboxamides in the endocannabinoid system.
Chicca A; Arena C; Bertini S; Gado F; Ciaglia E; Abate M; Digiacomo M; Lapillo M; Poli G; Bifulco M; Macchia M; Tuccinardi T; Gertsch J; Manera C
Eur J Med Chem; 2018 Jun; 154():155-171. PubMed ID: 29793210
[TBL] [Abstract][Full Text] [Related]
3. Development of
Intranuovo F; Brunetti L; DelRe P; Mangiatordi GF; Stefanachi A; Laghezza A; Niso M; Leonetti F; Loiodice F; Ligresti A; Kostrzewa M; Brea J; Loza MI; Sotelo E; Saviano M; Colabufo NA; Riganti C; Abate C; Contino M
J Med Chem; 2023 Jan; 66(1):235-250. PubMed ID: 36542836
[TBL] [Abstract][Full Text] [Related]
4. Beyond the Direct Activation of Cannabinoid Receptors: New Strategies to Modulate the Endocannabinoid System in CNS-Related Diseases.
Chicca A; Arena C; Manera C
Recent Pat CNS Drug Discov; 2016; 10(2):122-141. PubMed ID: 27630088
[TBL] [Abstract][Full Text] [Related]
5. Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice.
Nicolussi S; Viveros-Paredes JM; Gachet MS; Rau M; Flores-Soto ME; Blunder M; Gertsch J
Pharmacol Res; 2014 Feb; 80():52-65. PubMed ID: 24412246
[TBL] [Abstract][Full Text] [Related]
6. Correlating FAAH and anandamide cellular uptake inhibition using N-alkylcarbamate inhibitors: from ultrapotent to hyperpotent.
Nicolussi S; Chicca A; Rau M; Rihs S; Soeberdt M; Abels C; Gertsch J
Biochem Pharmacol; 2014 Dec; 92(4):669-89. PubMed ID: 25283614
[TBL] [Abstract][Full Text] [Related]
7. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
[TBL] [Abstract][Full Text] [Related]
8. N-Stearoyltyrosine protects primary cortical neurons against Aβ(1-40)-induced injury through inhibiting endocannabinoid degradation.
Cui H; Yang R; Liu S; Fu G; Lu Y
Life Sci; 2015 Mar; 124():91-100. PubMed ID: 25637682
[TBL] [Abstract][Full Text] [Related]
9. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
[TBL] [Abstract][Full Text] [Related]
10. Perinatal maternal high-fat diet induces early obesity and sex-specific alterations of the endocannabinoid system in white and brown adipose tissue of weanling rat offspring.
Almeida MM; Dias-Rocha CP; Souza AS; Muros MF; Mendonca LS; Pazos-Moura CC; Trevenzoli IH
Br J Nutr; 2017 Nov; 118(10):788-803. PubMed ID: 29110748
[TBL] [Abstract][Full Text] [Related]
11. Methylation and acetylation of 15-hydroxyanandamide modulate its interaction with the endocannabinoid system.
Amadio D; Fezza F; Catanzaro G; Incani O; van Zadelhoff G; Finazzi Agrò A; Maccarrone M
Biochimie; 2010 Apr; 92(4):378-87. PubMed ID: 20096328
[TBL] [Abstract][Full Text] [Related]
12. Endocannabinoid system: An overview of its potential in current medical practice.
Mouslech Z; Valla V
Neuro Endocrinol Lett; 2009; 30(2):153-79. PubMed ID: 19675519
[TBL] [Abstract][Full Text] [Related]
13. Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist.
Brizzi A; Aiello F; Marini P; Cascio MG; Corelli F; Brizzi V; De Petrocellis L; Ligresti A; Luongo L; Lamponi S; Maione S; Pertwee RG; Di Marzo V
Bioorg Med Chem; 2014 Sep; 22(17):4770-83. PubMed ID: 25065940
[TBL] [Abstract][Full Text] [Related]
14. Enhanced endocannabinoid tone as a potential target of pharmacotherapy.
Toczek M; Malinowska B
Life Sci; 2018 Jul; 204():20-45. PubMed ID: 29729263
[TBL] [Abstract][Full Text] [Related]
15. Endocannabinoid System: A Multi-Facet Therapeutic Target.
Kaur R; Ambwani SR; Singh S
Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of endocannabinoids.
Biernacki M; Skrzydlewska E
Postepy Hig Med Dosw (Online); 2016 Aug; 70(0):830-43. PubMed ID: 27516570
[TBL] [Abstract][Full Text] [Related]
17. The endocannabinoid system dual-target ligand N-cycloheptyl-1,2-dihydro-5-bromo-1-(4-fluorobenzyl)-6-methyl-2-oxo-pyridine-3-carboxamide improves disease severity in a mouse model of multiple sclerosis.
Arena C; Gado F; Di Cesare Mannelli L; Cervetto C; Carpi S; Reynoso-Moreno I; Polini B; Vallini E; Chicca S; Lucarini E; Bertini S; D'Andrea F; Digiacomo M; Poli G; Tuccinardi T; Macchia M; Gertsch J; Marcoli M; Nieri P; Ghelardini C; Chicca A; Manera C
Eur J Med Chem; 2020 Dec; 208():112858. PubMed ID: 33002735
[TBL] [Abstract][Full Text] [Related]
18. Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis.
Bari M; Battista N; Fezza F; Finazzi-Agrò A; Maccarrone M
J Biol Chem; 2005 Apr; 280(13):12212-20. PubMed ID: 15657045
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.
Dickason-Chesterfield AK; Kidd SR; Moore SA; Schaus JM; Liu B; Nomikos GG; Felder CC
Cell Mol Neurobiol; 2006; 26(4-6):407-23. PubMed ID: 16736384
[TBL] [Abstract][Full Text] [Related]
20. The endocannabinoid system in human keratinocytes. Evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase.
Maccarrone M; Di Rienzo M; Battista N; Gasperi V; Guerrieri P; Rossi A; Finazzi-Agrò A
J Biol Chem; 2003 Sep; 278(36):33896-903. PubMed ID: 12815050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]